Niemann-Pick Type A PerlQuest
“Perlara’s unique drug discovery platform and business model is a perfect fit for advancing our efforts in discovering existing compounds that can be repurposed, and new novel compounds that can be optimized for treating Niemann-Pick Type A,”
Co-Founder and President of Wylder Nation Foundation
We completed Stage 2 and identified overlapping hits between worm and patient fibroblast drug repurposing screens.
Launch your own PerlQuest
Still have questions about PerlQuests?
PerlQuest updates from our Blog
In December of 2016, Perlara partnered with Wylder Nation to initiate an NPA PerlQuest, a research and drug discovery program for Niemann Pick Type A disease. If you've been...
A few months ago, Taryn Sumabat blogged about development of a fly model of a Niemann-Pick Type A Disease. Here I’ll remind you of the progress she described, and update you...